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Abstract
Background: Currently, the serodiagnosis of cystic echinococcosis relies mostly on crude Echinococcus granulosus hydatid
cyst fluid as the antigen. Consequently, available immunodiagnostic tests lack standardization of the target antigen and, in
turn, this is reflected on poor sensitivity and specificity of the serological diagnosis.
Methodology/Principal Findings: Here, a chromatographic method enabling the generation of highly enriched Antigen 5
(Ag5) is described. The procedure is very easy, efficient and reproducible, since different hydatid cyst fluid (HCF) sources
produced very similar chromatograms, notwithstanding the clearly evident and extreme heterogeneity of the starting
material. In addition, the performance of the antigen preparation in immunological assays was preliminarily assessed by
western immunoblotting and ELISA on a limited panel of cystic echinococcosis patients and healthy controls. Following
western immunoblotting and ELISA experiments, a high reactivity of patient sera was seen, with unambiguous and highly
specific results.
Conclusions/Significance: The methods and results reported open interesting perspectives for the development of
sensitive diagnostic tools to enable the timely and unambiguous detection of cystic echinococcosis antibodies in patient
sera.
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Introduction
Cystic echinococcosis (CE) is caused by the larval form of
Echinococcus granulosus. The life cycle of this cestode involves
dogs and other canids as the definitive hosts, while intermediate
hosts are usually cattle, sheep, goats and pigs [1–2]. However, due
to the contamination of food and water sources with E. granulosus
eggs shed with canid feces, man can become an accidental
intermediate host and develop CE.
The greatest prevalence of CE in human and animal hosts has
been recorded in the countries of the temperate zones, including
parts of Eurasia, Australia, South America and Africa [3]. In most
of these countries the disease has never been eradicated, exposing
the population to the risk of reemergence in areas where CE was
once believed to be controlled. In Bulgaria, following the reduction
in control efforts, the incidence of CE in children peaked from 0.7
to 5.4/100000 between the 1970s and the mid-1990s. Similarly, in
Wales the prevalence of infected dogs has more than doubled
between 1993 (3.4%) and 2002 (8.1%) [4]. Outside the temperate
zones, Italy is also currently considered a medium to high risk
country for CE, with areas subjected to a significantly higher
prevalence due to extensive sheep farming. In these high-risk
areas, CE prevalence can represent a serious public health
problem; as an example, the Island of Sardinia records a
prevalence of 70–92.8% in sheep, 3–19% in dogs, 9.4% in cattle,
9.4–11.1% in pigs, and 1% in horses [5–6], while in the human
population the annual regional average record (Hospital discharge
rate) was 9.3 per 100000 inhabitants [7], with the occurrence of
over 1000 cases requiring surgery each year in Italy [8]. Early
diagnosis in humans is difficult, since the disease is typically
asymptomatic for a long period after infection. Diagnosis is usually
based on symptomatology, epidemiological data, and the com-
bined use of radiologic imaging and immunodiagnostic techniques
[9]. Imaging is mostly useful to assess the cyst stage and to
differentiate echinococcal cyst from benign cysts, cavitary tuber-
culosis, mycoses, abscesses, and benign or malignant neoplasms
[10]. On the other hand, serological tests might offer advantages
over radiological procedures, including early diagnosis of infection,
PLOS ONE | www.plosone.org 1 August 2014 | Volume 9 | Issue 8 | e104962
early treatment for a more effective chemotherapy, and close
follow-up monitoring programs [11]. To date, however, commer-
cially available immunoassays show unsatisfactory performances,
possibly due to the poor quality of antigen preparations.
The hydatid cyst fluid (HCF), collected from infected animals, is
the main source of antigens to be used for serological diagnosis.
This liquid is a mixture containing a wide range of proteins of both
parasite and host origin, the complexity and heterogeneity of
which has already been highlighted by the proteomic character-
ization of HCF collected from sheep, cattle and humans [12]. The
most abundant and immunogenic HCF proteins, despite the
countless controversial publications about their specificity
[1,2,13,14,15,16], are Antigen 5 (Ag5) and Antigen B (AgB)
[17–18]. Ag5 is an oligomeric thermolabile glycoprotein which
migrates as 57 kDa and 67 kDa bands in sodium-dodecyl
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) under
non-reducing conditions, and as 38 kDa and 22 kDa bands under
reducing conditions [19]. The immunodiagnostic power of the
protein is thought to be mostly related to the 38 kDa subunit,
which contains phosphorylcholine epitopes. These moieties have
been demonstrated to play an important role both in cross-
reactivity with sera of patients suffering from other diseases, and in
immunoreactivity of Ag5 [16]. AgB is an oligomeric thermostable
lipoprotein that dissociates, both under reducing and non reducing
conditions, into 8/12, 16, and 20/24 kDa subunits, suggesting that
it is composed of multimers of 8 kDa subunits [20–21].
During the last twenty years, many serological tests have been
proposed, based mostly on crude HCF, Ag5, and AgB, but their
diagnostic values have been proven to be limited in human
hydatidosis. This is probably due to a combination of factors,
including poor sensitivity and the lack of standardized antigen
preparations. Moreover, it is worth noting that many published
considerations refer to dated observations, often elaborated
without the currently available advanced protein analysis facilities
[22–25].
For all these reasons, an ex novo biochemical characterization of
sheep HCF was performed by size exclusion chromatography,
western immunoblotting, and mass spectrometry. We report here
the set up of a reproducible size exclusion chromatography
method that enables to obtain a highly enriched preparation of
native Ag5. To evaluate the immunological reactivity of this
antigen preparation, limited cohorts of sera from CE patient and
healthy controls were evaluated against HCF crude antigen
sample and against the Ag5 enriched chromatographic fraction.
As preliminary results, we report that the enriched preparation of
native Ag5 shows a very high and specific reactivity, both in
western immunoblotting and in ELISA platforms, revealing




A written informed consent was obtained from patients at the
time of sample collection. The study was approved by the ethics
committee of the local health authority of Sassari (Comitato di
Bioetica, ASL N. 1, Sassari), Prot N. 1123/L.
Collection of sheep HCF and human serum samples
HCF crude samples were collected in two different Sardinian
slaughterhouses (CE/IT2383M, Tula (SS) and CE/IT2078M,
Lula (NU)), after a permission obtained from these slaughterhouses
to use the animal parts from animals being processed as part of the
normal work of the abattoir. Fluid was aspirated from liver and
lung cysts found in infected sheep. The hydatid fluid was
centrifuged at 10006g at 4uC and the supernatant stored at 2
80uC. A total of 24 blood sera from CE patients and control
subjects were obtained from a sample archive at the Istituto
Zooprofilattico Sperimentale della Sardegna and were chosen by
examining the clinical records available for each patient and
control. All samples were leftovers from routine diagnostic
procedures and had originally been collected from CE patients
(n = 13) at the time of admission at the hospital. Negative sera were
from Sardinian healthy blood donors (n = 6) or patients admitted
at the hospital for other non-related diseases (n = 5). Diagnosis of
CE had been performed by clinical examination and imaging
according to standard clinical practice guidelines. Eight patients
were surgically treated following admission to hospital and clinical
diagnosis. CE was confirmed in all these cases by direct inspection
of parasite material.
SDS-PAGE
Four different HCF samples (from two lung and two liver cysts)
were thawed and centrifuged at 120006g at 4uC. The superna-
tants were then five-fold concentrated and desalted by ultrafiltra-
tion on centrifugal filter devices with a molecular mass cut-off of
10 kDa (Microcon YM-10, Millipore). For each sample, total
protein concentration, evaluated by the BCA assay (Pierce,
Thermo Scientific), was quantified before and after ultrafiltration.
Finally, Laemmli buffer with or without 400 mM dithiothreitol
(DTT) as a reducing agent was added to 20 mg of each sample
[26], and subjected to SDS-PAGE on 15% acrylamide gels using
the Mini-Protean system (Bio-Rad, Hercules, CA, USA).
After BCA assay, Laemmli buffer with or without 400 mM
DTT was added to four different aliquots (500 ng, 1 mg and 2 mg)
of size exclusion Ag5 fraction, and the samples were subjected to
SDS-PAGE on 4–10% acrylamide gel. Gel was stained by silver
nitrate procedures [27–28].
Western Immunoblotting
Western immunoblotting was performed as described previously
[29], with minor modifications. Briefly, proteins separated by
SDS-PAGE (on 15% or 4–10% acrylamide gels) were electrically
transferred onto nitrocellulose membranes and blocked in
phosphate buffered saline, pH 7.4, 0.05% Tween 20 (PBS–T),
containing 5% skim milk for 2 h. Membranes were then incubated
with sera (1:200 in PBS-T, 2% skim milk) for 1 h, either directly
on membranes containing antigen preparations loaded in individ-
ual wells of 10-well gels, or by using a multiscreen apparatus (Bio-
Rad) on membranes containing antigen preparations loaded in
single-well gels. After washing, membranes were incubated with
horseradish peroxidase conjugated anti-human IgG (Sigma)
diluted 1:500000 in 2% skim milk in PBS-T, developed with
ECL substrate (Sigma), and digitized with VERSA DOC 4000 MP
(Biorad).
Antigen 5 preparation
Ag5 fraction was obtained by Fast Protein Liquid Chromatog-
raphy (FPLC) procedures, performed on an AKTA Explorer 10
system (GE Healthcare). Aliquots of 5 mL of 5 sheep HCF were
desalted by HiPrep 26/10 column (GE Healthcare), lyophilized,
solubilized in 500 mL of 50 mM phosphate buffer at pH 7.6,
containing 150 mM NaCl (running buffer) and filtered at
12,0006g on PVDF 0.22 mm filters (Ultrafree-MC Centrifugal
Filter Units, Millipore). Size exclusion chromatography fraction-
ations were then performed on a Superdex-200 column (10/300
GL, GE Healthcare). Runs were performed at room temperature
at a flow rate of 1 mL/min. Column was calibrated, under the
Native Ag5 Enrichment from HCF
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same conditions, with standard proteins (thyroglobulin, apoferri-
tin, beta-amylase, BSA and carbonic anhydrase, Sigma Aldrich).
In situ hydrolysis and Mass Spectrometry analysis of gel
bands
Gel bands (selected ones or the whole lanes) were cut and
subjected to in situ hydrolysis as described previously [30]; briefly,
gel slices were destained, reduced in 50 mM NH4HCO3 buffer
with 10 mM DTT at 56uC and then carbamidomethylated in
50 mM NH4HCO3 buffer with 55 mM iodoacetamide at room
temperature in the dark. Tryptic digestion was performed at 37uC
overnight using variable amount (50–100 ng) of trypsin per gel
slice.
Peptide mixtures obtained by selected bands from HCF were
analyzed by LC-MS/MS on a XCT Ultra 6340 ion trap equipped
with a 1200 HPLC system and a chip cube (Agilent Technologies,
Palo Alto, CA). After loading, peptides were concentrated and
desalted at 4 ml/min on a 40 nL enrichment column, with 0.2%
formic acid and then fractionated on a C18 reverse-phase
(75 mm643 mm, Agilent Technologies Chip) at a flow rate of
300 nl/min, with a linear gradient of eluent B (0.2% formic acid in
95% acetonitrile) in A (0.2% formic acid in 5% acetonitrile) from 3
to 60% in 20 min. MS method parameters were as follows:
Capillary voltage 1730 V. Trap ICC smart target was 300000
units and maximal accumulation time was 100 ms. MS/MS was
operated at a fragmentation amplitude of 1.3 V, and threshold
ABS was 6000 units. Scan speed was set in ‘‘standard-enhanced’’
mode at 8100 (m/z)sec21 for MS and ‘‘ultra scan’’ mode at 26000
(m/z)sec21 for MS/MS scans. Peptide analysis was performed
scanning from m/z 250 to m/z 2200 in AutoMS (n) precursor
selection mode of the three most intense ions (fragmentation mass
range from 100 to 2200 m/z). Dynamic exclusion was used to
acquire a more complete survey of the peptides by automatic
recognition and temporary exclusion (0.15 min) of ions from
which definitive mass spectral data had previously acquired.
Helium was used as the collision gas. Data Analysis software (6300
Series Ion Trap LCMS), provided by the manufacturer, was used
to analyze raw MS and MS/MS spectra and to generate peak lists,
as MGF files.
The whole lane analysis (GeLC-MS/MS) of Ag5 fraction from
size exclusion chromatography was performed on a Q-TOF
hybrid mass spectrometer equipped with a nano lock Z-spray
source and coupled on-line with a nanoAcquity chromatography
system (Waters). The peptide mixture was concentrated and
washed onto a Trap column (Symmetry 100 A˚, 5 mm, C18,
180 mm620 mm, Waters) using 0.2% formic acid, and fraction-
ated onto a C18 RP column (NanoAcquity UPLC 1.7 mm
BEH130 C18 75 mm6150 mm, Waters) at a flow rate of
250 nL/min. The samples were fractionated using a linear
gradient of eluent B (0.2% formic acid in 95% ACN) in eluent
A (0.2% formic acid) from 0.5 to 50% B in 46 minutes. The mass
spectrometer was set up in a data-dependent MS/MS mode where
a full-scan spectrum was followed by tandem mass spectra,
selecting peptide ions as the three most intense peaks of the
previous scan. MS method parameters were as follows: Capillary
voltage 2000 V, Scan time 0.5 sec in MS and 1 sec in MSMS.
Peptide analysis was performed scanning from m/z 300 to m/z
1600 in MS and from 100 to 2000 m/z in MSMS. Dynamic
exclusion was used to acquire a more complete survey of the
peptides by automatic recognition and temporary exclusion
(10 sec) of ions from which definitive mass spectral data had
previously acquired. Argon was used as the collision gas, and
collision energy depending on mass and charge of the precursor
ion was applied. ProteinLynx software (Version 2.2.5), was used
for analysis of raw MS and MS/MS spectra and the production of
the pkl lists.
Both the peak lists from Q-TOF analysis, converted into a MGF
file, and the MGF files from Ion Trap mass spectrometer were
analyzed by Proteome Discoverer software (version 1.4; Thermo
Scientific, Bremen, Germany) using Sequest-HT as search engine
for protein identification, according to the following criteria:
Database UniprotKB (release 2014_02), taxonomy Mammalia
integrated with Echinococcus granulosus [31–32], enzyme trypsin,
precursor mass tolerance 30 ppm and fragment mass tolerance
0.3 Da for Q-TOF analysis, mass tolerance 200 ppm and
fragment mass tolerance 0.6 Da for Ion Trap analysis, cysteine
carbamidomethylation as static modification and N-terminal
glutamine conversion to pyroglutamic acid and methionine
oxidation as dynamic modifications. The percolator algorithm
was used for protein significance (p-value,0.01) and for peptide
validation (peptide confidence: q-value,0.05). Only rank 1
peptides and only proteins identified with at least two peptides
and two spectral counts were considered.
Data analysis
Protein abundance was expressed by means of the normalized
spectral abundance factor (NSAF). NSAF was calculated as
follows: NSAF~ SAFi=
PN
i~ 1 SAFi , where subscript i denotes
a protein identity and N is the total number of proteins, while SAF
is a protein spectral abundance factor that is defined as the protein
spectral counts divided by its length (number of residues or
molecular weight). In this approach, the spectral counts of each
protein were divided by its length and normalized to the total sum
of spectral counts/length in a given analysis [33].
ELISA
For indirect ELISA tests, microplates (Nunc-Maxisorp Immu-
noplate) were coated with Ag5 fraction by depositing in each well
100 mL of a 100 ng/mL antigen solution in PBS. Plates were then
incubated at 37uC until completely dried [34], washed with 0.05%
Tween in PBS (PBS-T), and incubated for 1 h at 37uC in blocking
solution (5% bovine serum albumin (BSA) in PBS-T). After
washing with PBS-T, sera were added at 1:500 dilution in 2% BSA
in PBS-T and incubated at 37uC for 1 hour. Secondary antibody
(horseradish peroxidase conjugated anti-human IgG, Sigma) was
diluted 1:100000 in 2% BSA in PBS-T and incubated at 37uC for
1 hour. Finally, the substrate (3.39, 5.59-Tetramethyl-benzidine
Liquid Substrate, Supersensitive, Sigma) was added. Wells were
washed five times with PBS-T between the application of sera and
the secondary antibody, as well as between the application of the
secondary antibody and the substrate. The absorbance was read at
620 nm at 159, 309 and 1 hour of incubation on a Tecan Sunrise
microplate reader. The readings were taken at different time
points to find out the best performing incubation time, and then
only 60 min incubation times were considered for calculations. All
sera were tested in duplicate, and net absorbances were calculated
by subtracting the reactivity of the secondary antibody and
substrate alone. Threshold value was established as the mean +
2SD of all the negative controls. All patient sera were also tested in
parallel with four commercially available ELISA kits for CE
diagnosis according to the user instructions provided (Euroimmun,
DRG, MP biomedicals, Serion). All net absorbance values were
used for statistical calculations (Student’s t-test) and for plotting the
results obtained with sera from CE positive patients and controls
using Microsoft Excel (Microsoft, Redmond, WA).
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Results
SDS-PAGE of sheep HCF
A total of 4 different HCF samples collected from hydatid cysts,
two localized in the lung and two in the liver of infected sheep,
were concentrated and desalted by ultrafiltration and then
analyzed by SDS-PAGE under non-reducing and reducing
conditions (Figure 1). Protein concentration, quantified before
and after ultrafiltration, revealed heterogeneous values among the
four samples. Indeed, even though 20 mg of sample was loaded in
each lane, this protein amount was reached by using different
volumes for the 4 fluids. An extreme variability was observed not
only in HCF protein concentration, but also in its protein
composition, as clearly evident when comparing the different band
distribution and their relative abundance (lanes 1–4 as well as
lanes 5–8) probably due to presence of both host and parasite
proteins in variable amounts. Therefore, a strategy for fraction-
ation and characterization of the fractions was devised.
Western immunoblotting on sheep cystic fluid and LC-
MS/MS characterization of reactive bands
In order to characterize the reactivity and specificity of
antibodies in sera of CE patients, a pool of crude HCF antigen
preparation was subjected to western blotting analysis on a
multiscreen apparatus. HCF was run under non-reducing and
reducing conditions and resulting membranes were both incubat-
ed with a collection of 24 sera, 13 of which were from CE patients
and the other 11 were from healthy controls. As an example,
Figure 2 shows the results obtained with 3 CE patients and 3
healthy controls. Reactivity against numerous protein bands was
observed for CE patients (1–3), together with few bands also for
control sera (14–16). Moreover, patients 1–3 showed different
behaviours, both in non reducing and reducing conditions. More
in detail, only serum 1 recognized a band triplet at about 8-16-
24 kDa in both the experimental conditions used, while showing a
faint signal for a 38 kDa band in reducing conditions.
To shed light on the identity of the proteins which gave
reactivity in CE patients and to gather information on the HCF
composition, an SDS-PAGE of HCF was performed and the gel
was cut in two parts; one half was subjected to a western blot
experiment with serum 1, whilst the second half was Coomassie
stained and used for protein identification by tryptic digestion
followed by tandem mass spectrometry (LC-MS/MS) analysis
(Figure 3). More in detail, by comparing the two parts of the gel,
the areas corresponding to the reactive bands on the western blot
image were excised from the stained gel and subjected to
identification. The complete list of protein identities is reported
in Table 1, and all the details about the identifications are
reported in Table S1. As a result, the strongly reactive bands
observed at about 8-16-24 kDa only with serum 1 in both
conditions were identified as AgB, with its typical ladder-like
pattern (bands 2, 3, 4, 6, 7, 8 Figure 3), while the 38 kDa band
seen in reducing conditions for sera 2 and 3 was identified as Ag5
(band 5 Figure 3). The prominent reactive band seen at 60 kDa in
non-reducing conditions for all three CE patient sera (band 1
Figure 3) was identified as Ag5. In general, therefore, CE patient
sera displayed a homogeneous reactivity for the non-reduced Ag5
60 kDa band and a heterogeneous reactivity for AgB and for the
reduced Ag5 38 kDa band. Control sera displayed a light
reactivity, most likely non-specific and directed against both
parasite and host proteins present in the crude HCF preparation.
Size exclusion chromatography of sheep HCF and
fraction characterization
The strongest and immunodominant reactivity observed in
patient sera was directed against native, non-denatured Ag5.
Hence, a separation protocol by size exclusion chromatography
was developed and optimized in order to attain an Ag5 enriched
preparation under native conditions (Figure 4A). The main
chromatographic fractions generated from all HCF samples,
indicated with numbers from 1 to 4, were collected and analyzed
by SDS-PAGE under non-reducing and reducing conditions, and
probed by immunoblotting with two representative patient sera
(Figure 4B and 4C). As a result, western blot analysis showed that
Ag5 was mainly contained in fraction 2, whilst AgB was mainly
eluted in fraction 3; moreover, the reduced Ag5 38 kDa band was
only weakly recognized by serum 1 (Figure 4B, lane 2r); finally,
AgB was recognized only by serum 1 in fraction 3 (Figure 4B,
lanes 3-3r).
As clearly evident in Figure 4A, the Ag5 preparation procedure
is highly reproducible, despite the extreme heterogeneity seen in
the protein abundance profile of different HCF samples, as already
highlighted by SDS-PAGE (Figure 1). Indeed, the elution volume
of the Ag5 fraction was consistently at 9.50 mL, for all the five
HCF runs, demonstrating the robustness and reproducibility of
this procedure.
According to the standard curve performed on the size
exclusion column, the apparent native molecular weight of Ag5
was of at least 600 kDa, corresponding to an oligomeric structure
of about ten units, or to a native protein complex involving Ag5. In
order to investigate this issue, an SDS-PAGE of fraction 2 was run
and silver stained (Figure 5A). Both whole lanes corresponding to
2 mg of non-reduced and reduced fraction 2 (lanes 3N-3R) were
analyzed by GeLC-MS/MS and the identifications revealed the
fraction 2 composition (Table 2 and Table S2). Adding to Ag5, the
high molecular weight bands observed both in western blots in
Figure 4 (lane 2 and 2r) and in electrophoresis in Figure 5A (bands
a and b in lanes 3N and 3R) could be reasonably attributed to the
basement membrane specific heparan sulfate protein (identified in
bands 3Na and 3Ra), peroxidasin (identified in bands 3Na, 3Nb
Figure 1. SDS-PAGE separation of sheep HCF. Two lung (lanes 1–
2, 5–6) and two liver (lanes 3–4, 7–8) HCF samples were separated
under non-reducing (N, lanes 1–4) and reducing conditions (R, lanes 5–
8) by SDS-PAGE on 15% acrylamide gels. Each sample was loaded after
concentration and desalting by ultrafiltration. Due to the different
starting protein concentrations, different volumes of each sample,
ranging from 7.5 mL to 17.5 mL, where used to reach loads of 20 mg/
lane. Coomassie Blue staining was performed. Lane M: molecular
weight markers.
doi:10.1371/journal.pone.0104962.g001
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and 3Rb) and neurogenic locus notch protein (identified in bands
3Na and 3Rb), according to MS identifications of single bands
(Table 2). However, it cannot be excluded that the observed
immunoreactivity is still due to the Ag5 migrating in these higher
molecular weight bands.
By using this data, label free quantitation with the spectral count
approach applied to lane 3R allowed also to provide a rough
estimate of the relative protein content in fraction 2. As described
in Figure 5B, after size exclusion chromatography the Ag5
percentage content in the analyzed fraction was estimated to be
Figure 2. Western immunoblotting of human sera against crude HCF. Membranes containing HCF antigen preparations, loaded in single-
well gels, were incubated with blood sera from CE patients (1–3) and control subjects (14–16) by using a multiscreen apparatus. Panel A and B show
sera reactivity against non-reduced and reduced (N and R) HCF, respectively. The approximate positions of AgB and Ag5 E. granulosus antigens are
indicated on the left. Positive sera 2 and 3 do not seem to recognize the typical ladder-like pattern of AgB in both conditions. On the other hand,
serum 1 recognizes only weakly the 38 kDa band putatively arising from Ag5 reduction (panel B). Moreover, control sera produce non specific
responses toward some protein components. Sera were tested in duplicate in at least three separate experiments. Molecular weight references are
indicated on the right.
doi:10.1371/journal.pone.0104962.g002
Table 1. List of identified proteins from selected SDS-PAGE bands of Figure 1.
Band Protein name Species Acc. No.a
NON REDUCED SAMPLE
1 Ag5 E. granulosus I1WXU1
Serum albumin O. aries P14639
2 Antigen B 4/1 E. granulosus D1MH02
Phosphatidylethanolamine-binding protein B. taurus P13696
3 Antigen B subunit 4 E. granulosus Q6UZD9
4 Antigen B 4/1 E. granulosus D1MH02
REDUCED SAMPLE
5 Ag5 E. granulosus I1WXU1
6 Antigen B 4/1 E. granulosus D1MH02
7 22 kDa antigen 5 E. granulosus D6R8R1
Phosphoenolpyruvate carboxykinase E. granulosus I3NX81
Antigen B 4/1 E. granulosus D1MH02
8 Antigen B subunit 2 E. granulosus Q6EJE1
aUniprotKB accession number.
doi:10.1371/journal.pone.0104962.t001
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63%, while the remaining proteins were 32% host proteins and
5% other E. granulosus proteins.
Western blotting on enriched native Ag5 fraction
To assess its diagnostic value, the chromatographic Ag5
preparation was assayed by immunoblotting on a multiscreen
apparatus, with a collection of 24 human sera available in this
study (Figure 6). An unambiguous reactivity of patient sera against
the non-reduced, enriched Ag5 fraction was observed, when
compared to the heterogeneous results seen with crude HCF
(Figure 2); moreover, a significant reduction in nonspecific signals
was detected with control sera.
Performance of the enriched native Ag5 preparation on
an ELISA platform and comparison with four commercial
ELISA assays
The suitability of the enriched Ag5 preparation to the ELISA
format was then evaluated on all patient and control sera (Ag5
ELISA). As a comparison, the same sera were also tested with four
ELISA kits currently used for serological evaluation of CE patients
(DRG, Serion, Euroimmun, and MP). Table 3 summarizes the
results obtained, and presents the specificity and sensitivity values
calculated for each test, while Table S3 and Figure 7 illustrate
absorbance values obtained for positive and control sera as values
and as boxplots, respectively. The data distribution reported in the
boxplots and the summary table demonstrate a better separation
of the patient and control groups with the Ag5 enriched antigen,
showing a greater sensitivity when compared to commercially
available ELISAs (Table 3), although the number of sera is too
limited to draw statistically supported conclusions. The Ag5
ELISA enabled the detection of antibodies against E. granulosus
in all clinically positive patients, while patients 4 and 5 tested
negative with all the HCF-based assays. In addition, patient 9
tested negative with three out of four commercial assays.
Specificity was also high when compared to the most specific
commercial assay, indicating that sensitivity can be increased
without incurring in detection of false positive results. Because of
the unavailability of sera, specificity was not evaluated for patients
with different parasitoses.
Discussion
Despite almost fifty years of active investigation, immunodiag-
nosis of CE [35] is still a challenge. Many assay platforms have
been devised, including indirect hemagglutination, latex aggluti-
nation, immunofluorescence, immunoelectrophoresis, western
immunoblotting, and ELISA [36–40], based on various antigen
preparations. In the last fifteen years, purified native, recombinant,
or synthetic proteins and peptides have been increasingly
evaluated, ranging from the well known Ag5 and AgB [18,41],
to the less popular malate dehydrogenase [15], P29 [42],
thioredoxin peroxidase [43], and the 89 kDa together with the
74 kDa protein described by Carmena [44], among others.
Currently, commercially available serological kits are mostly
based on ELISA and use crude HCF as target antigen because of
its ease of preparation, as well as for its availability in endemic
areas. However, in its crude form generally obtained from cysts
developed in infected sheep, this fluid contains a complex mixture
Figure 3. Immunoreactive bands subjected to mass spectrometry analysis. HCF was separated by SDS-PAGE and the resulting gel was cut
in two parts, one of them subjected to western blot experiment with serum 1, the other part stained and further processed for protein identification
Left: Immunoreactive profile observed by western immunoblotting on non-reduced (N) and reduced (R) HCF samples. Right: reactive bands excised
from the SDS-PAGE gel and subjected to LC-MS/MS identification. M: molecular weight markers.
doi:10.1371/journal.pone.0104962.g003
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of host proteins, mainly represented by blood serum proteins,
together with proteins released by E. granulosus. In this work,
SDS-PAGE and size exclusion chromatography (Figure 1 and
Figure 4) further underscore the extreme heterogeneity in the
protein concentration and composition of different sheep HCF
samples, both concerning total and host/parasite protein concen-
trations. As a consequence, the same volume of HCF can harbor
quite different amounts of E. granulosus antigens in relation to
Figure 4. Size exclusion chromatography of sheep HCF. A. Overlay of five HCF chromatograms showing the highly reproducible profile
achievable despite the heterogeneity of the starting samples. Aliquots of sheep HCF were desalted and loaded on a Superdex-200 column. Size
calibration marks, obtained from runs of standard proteins (thyroglobulin, apoferritin, beta-amylase, BSA and carbonic anhydrase), are indicated by
arrows in the chromatogram. B and C: the numbered peak fractions (1–4) were collected and analyzed by western immunoblotting, after SDS-PAGE
on 4–10% acrylamide gels, under non reducing and reducing (r) conditions. Two patient sera (serum 1, panel B, and serum 2, panel C, respectively)
were tested against all the fractions. Arrows indicate the position of Ag5 and AgB.
doi:10.1371/journal.pone.0104962.g004
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host proteins, leading to an extremely variable intensity of the
antibody response measured with serological assays, as well as to
the generation of non-specific signals; indeed, reactivity is often
seen also when testing sera from control subjects (Figure 3). This
reduced specificity requires the use of relatively high thresholds,
leading to false negative results in CE patients with low antibody
titers. Commercial ELISA kits based on crude HCF necessarily
suffer from this heterogeneity, being manufactured according to
standardized protocols, that do not take into account HCF quality.
To date, Ag5 and AgB are still considered to be the most
immunogenic E. granulosus antigens. In the last ten years, many
researchers have focused on the development of immunodiagnos-
Table 2. List of identified proteins from GeLC-MS/MS analysis of size exclusion chromatography fraction 2.
Protein name Species Acc. No.a Bandsb %c
NON REDUCED
Ag5 E. granulosus I1WXU1 3Na, 3Nb, 3Nc, 3Nd, 3Ne, 3Nf 74.6
Serum albumin O. aries P14639 3Na, 3Nd, 3Ne, 3Ng 17.1
Basement membrane specific heparan sulfate E. granulosus U6JHS5 3Na 0.5
Neurogenic locus notch protein E. granulosus U6JDN7 3Na 0.9
Fibronectin B. taurus P07589 3Na 0.7
Peroxidasin E. granulosus U6JLH4 3Na, 3Nb 1.3
Lysosomal alpha glucosidase E. granulosus U6JQ59 3Na, 3Nb, 3Nc 2.2
Alpha-2-macroglobulin B. taurus Q7SIH1 3Na 0.6
Cathepsin D lysosomal aspartyl protease E. granulosus U6J5K4 3Nc, 3Nd 2.0
Laminin E. granulosus U6JF91 3Nc 0.3
REDUCED
Ag5 E. granulosus I1WXU1 3Rb, 3Rc, 3Rd, 3Re, 3Rf, 3Rg 63.0
Serum albumin O. aries P14639 3Ra, 3Rb, 3Rc, 3Rd, 3Re, 3Rf, 3Rg 31.5
Peroxidasin E. granulosus U6JLH4 3Rb, 3Rf, 3Rg 2.2
Neurogenic locus notch protein E. granulosus U6JDN7 3Rb, 3Re 0.8
Basement membrane specific heparan sulfate E. granulosus U6JHS5 3Ra 0.2
Lysosomal alpha glucosidase E. granulosus U6JQ59 3Rc, 3Rf, 3Rg 0.9
Alpha-2-macroglobulin B. taurus Q7SIH1 3Ra, 3Rb, 3Rc 0.5
Fibronectin B. taurus P07589 3Rb 0.2
Laminin E. granulosus U6JF91 3Rd 0.5
aUniprotKB accession number.
bBands in which the protein was identified.
cPercentage content according to label free quantitation approach.
doi:10.1371/journal.pone.0104962.t002
Figure 5. SDS-PAGE and relative protein abundance of fraction 2 from size exclusion chromatography of sheep HCF. A: Laemmli
buffer with (R) or without 400 mM DTT (N) was added to aliquots of 500 ng (lanes 1N-1R), 1 mg (lanes 2N-2R) and 2 mg (lanes 3N-3R) of size exclusion
chromatography fraction 2, and subjected to SDS-PAGE on 4–10% acrylamide gel. Lane M: molecular weight markers. Gel was silver stained and then
analyzed by GeLC-MS/MS, by cutting lanes 3N and 3R in 7 bands (a–g) each. B: pie chart representing the relative protein abundance of fraction 2
from GeLC-MS/MS analysis of lane 3R. According to label free quantitation, Ag5 represents the most abundant component of the fraction, reaching
about 63% of the total content.
doi:10.1371/journal.pone.0104962.g005
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tic methods based on the recognition of both native and synthetic
AgB. However, as reported several years ago [45], and as
confirmed by western blotting in this work, a proportion of CE
patients with active cysts do not develop a detectable humoral
response against AgB (Figure 2, sera 2–3). On the other hand, the
use of Ag5, either partially or highly purified, has declined because
of the numerous references to potential cross-reactivity issues
[13,16], as well as to low sensitivity-specificity [1]. Many scientists
deduced their conclusions stating that part of this cross-reactivity
was associated with the presence of phosphorylcholine bound to
the 38 kDa subunit. However, it cannot be excluded that the
remaining part of cross-reactivity is associated to other causes,
such as the high heterogeneity of antigen preparations. When
examining the scientific literature on this matter, it emerges that
most studies reporting Ag5 cross-reactivity were performed
decades ago, when the sensitive analytical techniques currently
available had not yet been developed or were not so widespread in
research laboratories. This might have led to conclude that cross-
reactivity and low sensitivity-specificity issues were due to Ag5,
while a possible high heterogeneity of the antigen preparation
could have been the reason for its low diagnostic performance.
Considering that advanced methods for enrichment and in-depth
characterization of proteins are now available, enabling a
significant increase in robustness of diagnostic results, we have
conceived to reconsider Ag5 as the basis for immunoassay
development.
In addition, the choice to concentrate our efforts in developing
an efficient and reproducible procedure for the enrichment of Ag5
was encouraged by the western blotting results obtained with CE
patient sera on crude HCF proteins separated under non-reducing
conditions, where a clear and unambiguous antibody response to
the non-reduced Ag5 60 kDa band was consistently observed
(Figure 2, panel A). On the contrary, in many previous studies
evaluating Ag5, reducing agents were used, leading to generation
of a reduced Ag5 38 kDa band, related to its C-Terminal portion
[46]. According to our observations, reactivity to the reduced
protein (Figure 2, panel B) is not as reproducible as reactivity to
the non-reduced protein, supporting the choice of using non-
reduced Ag5 for performing serological testing.
The procedure described in this work enables the reproducible
preparation of native Ag5 from different HCF sources, notwith-
standing the clearly evident and extreme heterogeneity of the
starting material (Figures 1, 2, 3, 4).
The method is easy to perform and provides a very high
increase in Ag5 content, going up to about 63% in the reducing
conditions used for label free quantitation approach, when
compared to the starting HCF material; in fact, when applying
the same calculations to previously published data from Aziz and
coworkers [12], that accurately depict the sheep HCF composition
[12], it emerges that Ag5 represents only the 3.8% of the total
content of the starting material, although we cannot exclude that
Ag5 could be present in slightly higher amount in some HCF
samples, when considering the known heterogeneity of HCF. In
our experience, the total amount of Ag5 purified from 1 mL of
HCF spans from 1.5 to 3 mg.
The Ag5 preparation obtained with the method described in
this work is suitable for use as native antigen in immunoassays, as
suggested by the sensitive and specific reactivity observed by
western blotting against sera collected from CE patients and
control subjects (Figure 6). Western blotting, however, although
being a sensitive and specific method for assessing patient sera
reactivity against E. granulosus antigens, requires long execution
times, a fair amount of antigen, and a skilled person for assay
execution and result evaluation. More suitable to routine analysis
is the indirect ELISA, which combines reduced turnaround times,
ease of execution and result evaluation, with an increase in
sensitivity, enabling its application also for the wide screening of
high-risk categories, in differential diagnosis during early phase of
infection, and in patient follow-up for recurrence of infections. In
addition, the native Ag5 complex is a large molecule; size
exclusion chromatography and subsequent characterization of
the fraction by mass spectrometry and western blot analysis
revealed an Ag5 apparent molecular weight of at least 600 kDa, as
recently suggested by Monteiro and coworkers [47], instead of the
generally reported 400 kDa [19–20]. In fact, Ag5 has also been
identified in very high molecular weight bands (bands a and b of
Figure 5A), confirming the stability of the oligomer that does no
dissociate even in the strongly denaturing conditions adopted for
SDS-PAGE experiments. In addition, the Ag5 elution in the high
Figure 6. Western immunoblotting of human sera against Ag5 enriched preparation. Fraction 2 from size exclusion chromatography of
HCF was used as antigen in western blotting experiments under non-reducing conditions. Sera from CE patients (1–13) and control subjects (14–24)
were tested against a total of 300 ng of protein sample loaded in each single-well gel; this amount corresponds approximately to about 10 ng of
proteins per multiscreen slot. All CE patients sera react against the Ag5 protein band, although with a variable intensity probably depending on the
antibody titer of each serum. Moreover, control sera do not give any non-specific response. All sera were tested in at least three separate
experiments. The molecular weight region of Ag5 (60 kDa) is indicated on the left.
doi:10.1371/journal.pone.0104962.g006
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molecular weight fraction 2 could also be explained in terms of a
native protein complex involving Ag5 and other E. granulosus
proteins, the coelution of which, in the same chromatographic
fraction, we demonstrated by MS data analysis. One of these
proteins is the basement membrane specific heparan sulfate
protein; its presence in fraction 2, even if in low amounts (0.2%), is
in keeping with a stable complex with Ag5. Accordingly, other
authors [1,48], have already reported that the Ag5 22 kDa subunit
has heparan sulphate proteoglycans binding sites, suggesting that
the molecule provides interactions with cell surfaces and the
extracellular matrix.
The ELISA format, given the native conditions used, enables
preservation of native Ag5 complex conformation and, therefore,
provides better conditions for detection of antibodies with higher
efficiency and sensitivity. In a preliminary comparative evaluation
with four commercially available ELISA assays (Table 3 and
Figure 7), an enriched native Ag5 delivered higher sensitivity in
detecting clinically positive CE patients, including two patients
who tested negative with all the commercial assays, and one
patient who tested negative in three out of four commercial assays.
Taken toghether, our data suggest that the higher sensitivity seen
with the Ag5 ELISA is probably due to the quality of the antigen
preparation.
In conclusion, this work led to the development of a highly
reproducible and performing procedure for the rapid, easy and
inexpensive preparation of a native Ag5 based antigen. Notewor-
thy, this procedure can be further simplified and made less
expensive by employing a peristaltic pump, instead of an FPLC
system, to produce a controlled flow and, once standardized,
collecting a time fraction to recover the antigen. Consequently,
this method can be easily adopted by most laboratories with
average skills in biochemistry, opening the way to its extensive
validation. Indeed, while preliminary experiments demonstrated
the high performance of the enriched native Ag5 described in this
study in indirect ELISA-based immunoassays, its diagnostic value
needs to be confirmed by means of future large scale validation
studies.
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